<DOC>
	<DOCNO>NCT00716443</DOCNO>
	<brief_summary>Pliaglis® Cream versus compound topical anesthetic pain management Restylane® injection correction nasolabial fold .</brief_summary>
	<brief_title>Evaluate Efficacy , Safety &amp; Subject Satisfaction Pain Management With Pliaglis® Cream Dermal Filler Injections</brief_title>
	<detailed_description>Open-label , randomize study design assess effectiveness topical anesthetic ( Pliaglis® Cream ) versus compound topical anesthetic needle stick , immediately , one three hour Restylane® injection nasolabial fold .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Male Female Subjects 30 65 year age Subject undergoing cosmetic dermal filler injection correction nasolabial fold . Treatment sit comparable , require number injection nasolabial fold Subjects diagnose moderate nasolabial fold ( Wrinkle Severity Rating Scale grade 3 ) Subjects treatment dermatologic condition face , may interfere safe evaluation study treatment ( e.g . eczema , psoriasis , severe sundamage , dermatitis ) , damage , denude broken skin designate treatment site and/or scar infection area treat Subjects take prescription nonprescription analgesic medication 24 hour period prior procedure Subjects history bleed clot disorder Subjects use ASA ( aspirin ) , NSAIDs ( NonSteroidal Anti inflammatory Drugs ) , anticoagulant , St. John 's Wort high dos Vitamin E ( recommend daily allowance ) within 2 week prior procedure</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Nasolabial fold</keyword>
	<keyword>wrinkle</keyword>
	<keyword>topical anesthetic</keyword>
</DOC>